Braze

Valuation Analysis

About the Company

Braze en bref

Braze (BRZE) is currently trading at 21,61 € with a market capitalization of 2,4 Md €. The 52-week range spans from 13,23 € to 32,37 €; the current price is 33.2% below the yearly high. Year-over-year revenue growth stands at +30.2%.

💰 Dividende

Braze currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

20 analystes évaluent Braze (BRZE) au consensus : Achat Fort. L'objectif de cours moyen est de 29,87 €, soit un potentiel de +38.24% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 23,41 € à 43,35 €.

Braze : la thèse d'investissement en détail

Braze (BRZE) operates in the Technology — specifically Software - Application — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Top-line momentum is unusually strong with revenue expanding 30.2% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind. With a gross margin near 66.46%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Wall Street consensus sits at Strong Buy with an average price target implying roughly 38.24% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Short interest sits at 12.48% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

The PEG ratio at 1.3 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The analyst consensus price target implies 38.24% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (12.48%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Braze?

Compare top-rated brokers — low fees, trusted providers, fully regulated.